Head-to-head · WeighScore
Big Easy Weight Loss vs REMEVi
The verdict
Big Easy Weight Loss takes it — 75.3/100 to 73.5/100, but only just.
Big Easy Weight Loss grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Big Easy Weight Loss (joinbigeasy.com) is a New Orleans MD-run telehealth that ships compounded GLP-1 medication nationwide. REMEVi is close behind and may still be the better fit — see the factor split below.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Big Easy Weight Loss | REMEVi |
|---|---|---|
| WeighScore | 75.3/100 | 73.5/100 |
| Grade | C | C |
| Scorecard rank | #56 | #70 |
| Semaglutide | $133/mo (all doses, compounded) | $219/mo |
| Tirzepatide | $166/mo (all doses, compounded) | $319/mo |
| Coverage | All 50 states | All 50 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Yes |
Graded #56 · C
Strengths
- Low pricing: about 133 dollars per month for semaglutide, 166 for tirzepatide
- Site states it serves all 50 states with a 2 to 3 day pharmacy turnaround
- Names its partner compounding pharmacies and a Chief Medical Officer
Where it loses points
- Priced as 10 to 12-week packages rather than a simple monthly fee
- New-patient pricing is promotional and may rise on renewal
Graded #70 · C
Strengths
- A genuinely flat rate: 'the same price at every dose', stated as such, with no dose upcharge and no introductory rate to step off
- Longer terms are published openly rather than used as a teaser — semaglutide falls to $189 on 12 weeks and $149 on 52
- A daily oral semaglutide tablet is offered alongside the injection
- Available in all 50 states and DC, with no minimum commitment and no cancellation fee
Where it loses points
- The flat rate is the highest entry price of the top-scoring programmes here; the cheaper $149 figure needs a full year
- No FDA-approved brand-name pathway — the Wegovy and Ozempic pages are comparison content, not products
- Compounded semaglutide and tirzepatide are not FDA-approved finished products
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.